Reply
Hepatology
.
2022 Nov;76(5):E114-E115.
doi: 10.1002/hep.32645.
Epub 2022 Jul 16.
Authors
Gyongyi Szabo
1
,
Mack Mitchell
2
,
Craig J McClain
3
,
Srinivasan Dasarathy
4
5
,
Bruce Barton
6
,
Arthur J McCullough
4
5
,
Laura E Nagy
5
,
Aimee Kroll-Desrosiers
6
7
,
David Tornai
1
,
Hyesung Alice Min
6
,
Svetlana Radaeva
8
,
Lisa Casey
2
,
Jennifer Cuthbert
2
Affiliations
1
Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
2
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
3
Department of Medicine, University of Louisville, Louisville, Kentucky, USA.
4
Center for Microbiome and Human Health, Lerner Research Institute of the Cleveland Clinic, Cleveland, Ohio, USA.
5
Department of Inflammation and Immunity, Lerner Research Institute of the Cleveland Clinic, Cleveland, Ohio, USA.
6
Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
7
Veterans Affairs Central Western Massachusetts, Leeds, Massachusetts, USA.
8
National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.
PMID:
35778779
DOI:
10.1002/hep.32645
No abstract available
Grants and funding
1P50AA024337/NH/NIH HHS/United States
P50 AA024333/NH/NIH HHS/United States
R21 AR 071046/NH/NIH HHS/United States
RO1 AA028190/NH/NIH HHS/United States
RO1 DK113196/NH/NIH HHS/United States
RO1 GM119174/NH/NIH HHS/United States
U01 AA026977/NH/NIH HHS/United States
U01AA021890/NH/NIH HHS/United States
U01AA021901/NH/NIH HHS/United States
U01AA026938/NH/NIH HHS/United States
UH3 AA026970/NH/NIH HHS/United States
UO1 AA021890/NH/NIH HHS/United States
UO1 AA023902/NH/NIH HHS/United States
UO1 AA026933/NH/NIH HHS/United States
UO1 AA026976/NH/NIH HHS/United States
UO1 AA026976-03S1/NH/NIH HHS/United States
VA HSR&D funding